The Food and Drug Administration yesterday alerted health care providers and the public to three COVID-19 antigen tests that are not authorized or approved for distribution or use in the United States. Due to the potential for false results, FDA said providers should consider retesting patients with an authorized test if these tests was performed less than two weeks ago and they suspect an inaccurate result. 

In other testing news, President Biden last night announced that Americans will be able to order four more free at-home COVID-19 tests starting next week. 

Related News Articles

Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…
Headline
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…
Headline
The Food and Drug Administration authorized for marketing the first at-home over-the-counter test for COVID-19 using a traditional premarket review…